Reflections on the spread of metastasis to cancer prevention

Cancer Prevention Research

Volumn 4, Issue 3, 2011, Pages 324-328

  Mark Taketo, Makoto ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AES PROTEIN; ANTINEOPLASTIC AGENT; CANCER ANTIBODY; CHEMOKINE; CHEMOKINE RECEPTOR CCR ANTAGONIST; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR1 ANTAGONIST; CHEMOKINE RECEPTOR CXCR2; GAMMA SECRETASE INHIBITOR; NOTCH RECEPTOR; NOTCH RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

BLOOD CLOTTING; BONE MARROW CELL; CANCER INVASION; CANCER LOCALIZATION; CANCER MODEL; CANCER PREVENTION; CARCINOGENESIS; COLORECTAL CANCER; DRUG SELECTIVITY; DRUG TARGETING; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTESTINE METAPLASIA; LUNG TUMOR; METASTASIS INHIBITION; MULTIPLE SCLEROSIS; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SURGICAL WOUND; VASOCONSTRICTION; VISCERAL METASTASIS; WOUND HEALING;

ANIMALS; ANTICARCINOGENIC AGENTS; BONE MARROW CELLS; CHEMOPREVENTION; HUMANS; INFLAMMATION; MICE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; RECEPTORS, CCR1; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH; TREATMENT OUTCOME;

EID: 79955824434     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0046     Document Type: Review

References (29)

1. Nelson R. Survival rates increasing in metastatic colorectal cancer. Medscape Today 2010. Available from:http://www.medscape.com/viewarticle/703331 and http://www.cancer.gov/statistics.
2. Komarcevic A. The modern approach to wound treatment. Med Pregl 2000;53:363-8.
3. Gabriel A, Mussman J, de la Torre JI. Wound healing, growth factors. May 27, 2009. Available from: emedicine.medscapte.com.
4. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239-52.
5. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-44.
6. Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101-14.
7. DeNardo DG, Andreu P, Coussens LM. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev 2010;29:309-16.
8. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-40.
9. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-8. (Pubitemid 38082155)
10. +-myeloid cells that help invasion. Nat Genet 2007;39:467-75.
11. Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, et al. Abrogation of TGF-β signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008;13:23-35. (Pubitemid 350309741)
12. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-28. (Pubitemid 24324921)
13. Peeters CFJM, de Waal RMW, Wobbes T, Ruers TJM. Metastatic dormancy imposed by the primary tumor: Does it exist in humans? Annals Surg Oncol 2008;15:3308-15.
14. Weinberg RA. Multi-step tumorigenesis. In: The Biology of Cancer. New York: Garland Science;2007;Chapter 11:p.409.
15. Taketo MM, Edelmann W. Mouse models of colon cancer. Gastroenterology 2009;136:780-98.
16. Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM. Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 1998;92:645-56. (Pubitemid 28141513)
17. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci USA 1995;92;4482-6.
18. Kitamura T, Taketo MM. Keeping out the bad guys: gateway to cellular target therapy. Cancer Res 2007;67:10099-102. (Pubitemid 350070778)
19. Kitamura T, Fujishita T, Loetscher P, Revesz L, Hashida H, Kizaka-Kondoh S, et al. Inactivation of CCR1 suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci USA 2010;107:13063-8.
20. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
21. Miyaki M, Iijima T, Konishi M, Sakai K, Ishii A, Yasuno M, et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 1999;18:3098-103. (Pubitemid 29261230)
22. Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 2004;172:2853-60. (Pubitemid 38263670)
23. Wislez M, Fujimoto N, Izzo JG, Hanna AE, Cody DD, Langley RR, et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res 2006;66:4198-207.
24. Sonoshita M, Aoki M, Fuwa H, Aoki K, Hosogi H, Sakai Y, et al. Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell 2011;19:125-37.
25. Wu Y, Cain-Hom C, Choy L, Hagenbeek TJ, de Leon GP, Chen Y, et al. Therapeutic antibody targeting of individual Notch receptors. Nature 2010;464:1052-7.
26. Talmadge JE, Fidler IJ. The biology of cancer metastasis: Historical perspective. Cancer Res 2010;70:5649-69.
27. Häggström M. Phases of wound healing. 25 September 2010. Available from: http://en.wikipedia.org/wiki/File:Wound-healing-phases.png,
28. Adapted fromAsmussen PD, Sollner B. Mechanism of wound healing. In: Wound Care. Tutorial Medical Series. Stuttgart: Hippokrates Verlag, 1993.
29. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820-7. (Pubitemid 41753060)